Cytotoxic responses of carnosic acid and doxorubicin on breast cancer cells in butterfly-shaped microchips in comparison to 2D and 3D culture

Creative Commons License

Yildiz-Ozturk E., Gulce-Iz S. , Anil M., Yesil-Celiktas O.

CYTOTECHNOLOGY, vol.69, no.2, pp.337-347, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 69 Issue: 2
  • Publication Date: 2017
  • Doi Number: 10.1007/s10616-016-0062-3
  • Title of Journal : CYTOTECHNOLOGY
  • Page Numbers: pp.337-347
  • Keywords: Microfluidics, Microchip, Breast cancer, Carnosic acid, Doxorubicin, MICROFLUIDIC DEVICE, DRUG DISCOVERY, IN-VIVO, MODELS, MICROENVIRONMENTS, HYDROGEL, BIOLOGY, SYSTEMS, GROWTH


Two dimensional (2D) cell culture systems lack the ability to mimic in vivo conditions resulting in limitations for preclinical cell-based drug and toxicity screening assays and modelling tumor biology. Alternatively, 3D cell culture systems mimic the specificity of native tissue with better physiological integrity. In this regard, microfluidic chips have gained wide applicability for in vitro 3D cancer cell studies. The aim of this research was to develop a 3D biomimetic model comprising culture of breast cancer cells in butterfly-shaped microchip to determine the cytotoxicity of carnosic acid and doxorubicin on both estrogen dependent (MCF-7) and independent (MDAMB231) breast cancer cells along with healthy mammary epithelial cells (MCF-10A) in 2D, 3D Matrigel (TM) and butterfly-shaped microchip environment. According to the developed mimetic model, carnosic acid exhibited a higher cytotoxicity towards MDAMB 231, while doxorubicin was more effective against MCF-7. Although the cell viabilities were higher in comparison to 2D and 3D cell culture systems, the responses of the investigated molecules were different in the microchips based on the molecular weight and structural complexity indicating the importance of biomimicry in a physiologically relevant matrix.